Equity Details
Price & Market Data
Price: $5.01
Daily Change: +$0.01 / 0.20%
Daily Range: $4.83 - $5.09
Market Cap: $137,005,696
Daily Volume: 341,698
Performance Metrics
1 Week: -3.28%
1 Month: -3.65%
3 Months: -38.15%
6 Months: -45.01%
1 Year: -26.65%
YTD: -35.02%
About Journey Medical Corporation (DERM)
Access a quick overview of Journey Medical Corporation (DERM). Trading at 5.01, the stock recorded a daily change of +$0.01 / 0.20%. Its market cap is 137,005,696. Discover its performance over 3 months (-38.15%) and 6 months (-45.01%).
Company Details
Employees: 58
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also provides Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Emrosi for the treatment of inflammatory lesions of rosacea; Exelderm cream and solution for the treatment of fungal skin infections; and Targadox, an oral doxycycline drug for adjunctive therapy for severe acne, as well as Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. The company was formerly known as Coronado Dermatology, Inc. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.